Committee hears DFR warning on S154 biomarker testing study and potential state costs
State insurance deputy commissioner Mary Block told the committee S154 is currently a study but is narrowly written; she warned that if CMS finalizes a proposed rule requiring 'defrayal' for post-2011 mandates, the state could face significant premium costs and recommended broader, less prescriptive study language.
The full story
The committee on health care heard from Mary Block, deputy commissioner of insurance for DFR, on a proposed study bill, S154, that would examine mandating biomarker testing and its likely effects on insurance premiums.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or
Free account
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in